Synthesis and structure-activity relationships of novel 2',2'-difluoro analogues of docetaxel

被引：0

作者：

Uoto, K ^{[1
]}

Ohsuki, S ^{[1
]}

Takenoshita, H ^{[1
]}

Ishiyama, T ^{[1
]}

Iimura, S ^{[1
]}

Hirota, Y ^{[1
]}

Mitsui, I ^{[1
]}

Terasawa, H ^{[1
]}

Soga, T ^{[1
]}

机构：

[1] DAIICHI PHARMACEUT CO LTD, NEW PROD RES LABS 4, EDOGAWA KU, TOKYO 134, JAPAN

来源：

CHEMICAL & PHARMACEUTICAL BULLETIN | 1997年 / 45卷 / 11期

关键词：

docetaxel; paclitaxel; 2'; 2'-difluoro analogue; structure-activity relationship; cytotoxicity; microtubule disassembly-inhibitory activity;

D O I：

暂无

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

To investigate the role of the 2'-hydroxy group at the C-13 side chain of docetaxel in the antitumor activity, we prepared several 2',2'-difluoro derivatives of docetaxel and evaluated their cytotoxicity against mouse leukemia and human tumor cell lines and their microtubule disassembly-inhibitory activity. These analogues were prepared by esterification of protected 10-deacetylbaccatin III (21) with appropriate alpha,alpha-difluorinated carboxylic acids (Charts 1 and 2). Among these 2',2'-difluorodocetaxel derivatives, 2',2'-difluorodocetaxel (23b) was approximately 3-10 times as active as 2'-fluorodocetaxel (29a) in terms of cytotoxicity. In addition, the 3'-(2-furyl) (23h) and 3'-(2-pyrrolyl) (23p) analogues showed activity comparable or superior to that of docetaxel (2).

引用

页码：1793 / 1804

页数：12

共 50 条

[31] Structure-activity relationships of globomycin analogues as antibiotics
Kiho, T
Nakayama, M
Yasuda, K
Miyakoshi, S
Inukai, M
Kogen, H
BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (02) : 337 - 361
[32] STRUCTURE-ACTIVITY RELATIONSHIPS IN A SERIES OF COLCHICINE ANALOGUES
SCHINDLER, R
BIOCHEMICAL PHARMACOLOGY, 1961, 8 (01) : 145 - &
[33] Structure-activity relationships of bisphosphonate analogues.
Coxon, F. P.
Rojas, J.
Stewart, C. A.
Al Jaber, J.
Ebetino, F. H.
McKenna, C. E.
Kashemirov, B. A.
Mallard-Favier, I.
Rogers, M. J.
JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S166 - S166
[34] Investigation of the Structure-Activity Relationships of Psilocybin Analogues
Klein, Adam K.
Chatha, Muhammad
Laskowski, Lauren J.
Anderson, Emilie, I
Brandt, Simon D.
Chapman, Stephen J.
McCorvy, John D.
Halberstadt, Adam L.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2021, 4 (02) : 533 - 542
[35] Structure-activity relationships among desazadesferrithiocin analogues
Bergeron, RJ
Wiegand, J
McManis, JS
Weimar, WR
Huang, GF
IRON CHELATION THERAPY, 2002, 509 : 167 - 184
[36] CHEMISTRY AND STRUCTURE-ACTIVITY RELATIONSHIPS OF AMPHENONE ANALOGUES
BENCZE, WL
ALLEN, MJ
JOURNAL OF MEDICINAL & PHARMACEUTICAL CHEMISTRY, 1959, 1 (05): : 395 - 406
[37] Combined NK1 and N2 tachykinin receptor antagonists:: Synthesis and structure-activity relationships of novel oxazolidine analogues
Nishi, T
Fukazawa, T
Ishibashi, K
Nakajima, K
Sugioka, Y
Iio, Y
Kurata, H
Itoh, K
Mukaiyama, O
Satoh, Y
Yamaguchi, T
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (06) : 875 - 880
[38] Epibatidine isomers and analogues: Structure-activity relationships
White, Richard
Malpass, John R.
Handa, Sandeep
Baker, S. Richard
Broad, Lisa M.
Folly, Liz
Mogg, Adrian
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (21) : 5493 - 5497
[39] Synthesis and Structure-Activity Relationships of Novel Neocryptolepine Derivatives
El-Gokha, Ahmed A.
Boshta, Nader M.
Hussein, Mona K. Abo
El Sayed, Ibrahim El-T.
CHEMICAL RESEARCH IN CHINESE UNIVERSITIES, 2017, 33 (03) : 373 - 377
[40] Synthesis and structure-activity relationships of novel neocryptolepine derivatives
Ahmed A. El-Gokha
Nader M. Boshta
Mona K. Abo Hussein
Ibrahim El-T. El Sayed
Chemical Research in Chinese Universities, 2017, 33 : 373 - 377

← 1 2 3 4 5 →